Supreme Court Orders Federal Circuit to Reconsider Patent-Eligibility of Genes Just six days after it handed down its decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., the Supreme Court vacated the Federal Circuit’s decision in Association for Molecular Pathology v. United States Patent and Trademark Office, ordering the appellate court to reconsider the case in light of the Prometheus decision. Order granting cert., vacating […] Continue Reading →
Supreme Court Clarifies Patentability of Medical Treatments The Supreme Court recently handed down its unanimous decision in Mayo Collaborative Services v. Prometheus Laboratories, Inc., No. 10-1150, slip op. (March 20, 2012). The Court specifically considered the patentability of a method for determining the effective levels of a drug to be administered to a patient, and found the claims in question to be […] Continue Reading →